Back to Search Start Over

Expanding the Availability of Scalp Cooling to All Patients at Risk of Chemotherapy-Induced Alopecia

Authors :
Portia Lagmay-Fuentes
Andrea Smith
Shannon Krus
Laurie Lewis
Asma Latif
Tiffany Gagliardo
Manpreet Kohli
Source :
Journal of Market Access & Health Policy, Vol 12, Iss 3, Pp 158-168 (2024)
Publication Year :
2024
Publisher :
Taylor & Francis Group, 2024.

Abstract

Alopecia is an undesirable side effect of cancer chemotherapy. The mitigation of alopecia is a desirable adjunct treatment for patients with cancer. FDA-cleared scalp cooling (SC) devices have been successfully used to prevent or reduce chemotherapy-induced alopecia (CIA). This paper provides an understanding of the implementation and value of the new Insurance-Based Billing Model used in the USA for SC and its benefits compared with the original self-pay model. This improved compensation change will result in all patients in need, including underserved and disadvantaged populations, receiving equitable healthcare by allowing access to this valuable supportive care technology.

Details

Language :
English
ISSN :
20016689
Volume :
12
Issue :
3
Database :
Directory of Open Access Journals
Journal :
Journal of Market Access & Health Policy
Publication Type :
Academic Journal
Accession number :
edsdoj.37682ba670f240bd9dfa6891b94149c2
Document Type :
article
Full Text :
https://doi.org/10.3390/jmahp12030013